99 related articles for article (PubMed ID: 26905110)
1. Symptomatic Cytomegalovirus reactivation related to chemoradiotherapy for adenocarcinoma of lower third esophagus and gastro-esophageal junction cancer.
Ishi SV; Joshi A; Noronha V; Prabhash K
Indian J Cancer; 2015; 52(3):280-1. PubMed ID: 26905110
[No Abstract] [Full Text] [Related]
2. [Role of papillomavirus in adenocarcinoma of esophagogastric junction].
Zhang J; Tian XY; Wu XJ; Zong XL; Wu J; Ji JF
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2259-62. PubMed ID: 21029672
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
McNamara MJ; Adelstein DJ; Bodmann JW; Greskovich JF; Ives DI; Mason DP; Murthy SC; Rice TW; Saxton JP; Sohal D; Stephans K; Rodriguez CP; Videtic GM; Rybicki LA
J Thorac Oncol; 2014 Oct; 9(10):1561-7. PubMed ID: 25170643
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Esophageal Cancer in a Patient with CMV Reactivation after Neoadjuvant Chemoradiation Therapy].
Megumi K; Okumura H; Shimonosono M; Ijichi T; Uchikado Y; Omoto I; Yo H; Kita Y; Uenosono Y; Arigami T; Mori S; Baba K; Ishigami S; Owaki T; Natsugoe S
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1307-9. PubMed ID: 26489581
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
6. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
[No Abstract] [Full Text] [Related]
7. [A case of adenocarcinoma of the esophagogastric junction successfully treated with chemoradiation therapy].
Ebisui C; Okada K; Nishigaki T; Owada Y; Nagase H; Mukai R; Momozane T; Murakami M; Ide Y; Yanagisawa T; Murata K; Yokouchi H; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2143-5. PubMed ID: 22202310
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis.
Kitagawa K; Okada H; Miyazaki S; Funakoshi Y; Sanada Y; Chayahara N; Mayahara H; Fujii M
Cancer Med; 2021 Nov; 10(21):7525-7533. PubMed ID: 34514723
[TBL] [Abstract][Full Text] [Related]
9. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
Baldus SE
Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
[No Abstract] [Full Text] [Related]
11. Staging of adenocarcinoma of the gastroesophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
[TBL] [Abstract][Full Text] [Related]
12. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
13. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Lordick F; Ott K; Krause BJ
Dtsch Med Wochenschr; 2011 May; 136(20):1061-6. PubMed ID: 21560108
[No Abstract] [Full Text] [Related]
15. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced adenocarcinoma of esophagogastric junction with severe esophageal invasion effectively treated by chemoradiotherapy using paclitaxel and cisplatin, and S-1 after chemoradiotherapy].
Fujiwara H; Koeda K; Konosu M; Hosoi N; Tamasawa Y; Sase M; Tsukahara T; Ushio A; Taguchi M; Wakabayashi G
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1683-6. PubMed ID: 21996967
[TBL] [Abstract][Full Text] [Related]
17. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
18. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Mason DP; Rodriguez CP; Ives DI
J Thorac Oncol; 2009 Oct; 4(10):1264-9. PubMed ID: 19668013
[TBL] [Abstract][Full Text] [Related]
19. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
